Literature DB >> 20235882

A National Heart, Lung, and Blood Institute history and perspective on lymphangioleiomyomatosis.

Hannah Peavy1, Dorothy Gail, James Kiley, Susan Shurin.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20235882      PMCID： PMC2939846          DOI： 10.1089/lrb.2009.0023

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN： 1539-6851            Impact factor:   2.589


× No keyword cloud information.
  22 in total

1.  Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.

Authors:  T Carsillo; A Astrinidis; E P Henske
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism.

Authors:  Magdalena Karbowniczek; Aristotelis Astrinidis; Binaifer R Balsara; Joseph R Testa; James H Lium; Thomas V Colby; Francis X McCormack; Elizabeth Petri Henske
Journal:  Am J Respir Crit Care Med       Date:  2002-10-31       Impact factor: 21.405

3.  Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.

Authors:  M van Slegtenhorst; R de Hoogt; C Hermans; M Nellist; B Janssen; S Verhoef; D Lindhout; A van den Ouweland; D Halley; J Young; M Burley; S Jeremiah; K Woodward; J Nahmias; M Fox; R Ekong; J Osborne; J Wolfe; S Povey; R G Snell; J P Cheadle; A C Jones; M Tachataki; D Ravine; J R Sampson; M P Reeve; P Richardson; F Wilmer; C Munro; T L Hawkins; T Sepp; J B Ali; S Ward; A J Green; J R Yates; J Kwiatkowska; E P Henske; M P Short; J H Haines; S Jozwiak; D J Kwiatkowski
Journal:  Science       Date:  1997-08-08       Impact factor: 47.728

4.  Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM).

Authors:  Elena A Goncharova; Dmitry A Goncharov; Andrew Eszterhas; Deborah S Hunter; Marilyn K Glassberg; Raymond S Yeung; Cheryl L Walker; Daniel Noonan; David J Kwiatkowski; Margaret M Chou; Reynold A Panettieri; Vera P Krymskaya
Journal:  J Biol Chem       Date:  2002-06-03       Impact factor: 5.157

5.  Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.

Authors:  T A Smolarek; L L Wessner; F X McCormack; J C Mylet; A G Menon; E P Henske
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

6.  Subplasmalemmal linear densities in cells of the mononuclear phagocyte system in lung.

Authors:  O Kawanami; V J Ferrans; R G Crystal
Journal:  Am J Pathol       Date:  1980-07       Impact factor: 4.307

7.  Identification and characterization of the tuberous sclerosis gene on chromosome 16.

Authors: 
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

8.  Intraluminal fibrosis in interstitial lung disorders.

Authors:  F Basset; V J Ferrans; P Soler; T Takemura; Y Fukuda; R G Crystal
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

9.  Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis.

Authors:  Angelo M Taveira-DaSilva; Mario P Stylianou; Carolyn J Hedin; Arnold S Kristof; Nilo A Avila; Antoinette Rabel; William D Travis; Joel Moss
Journal:  Am J Respir Crit Care Med       Date:  2003-09-04       Impact factor: 21.405

10.  Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis.

Authors:  D Mark Davies; Simon R Johnson; Anne E Tattersfield; J Chris Kingswood; Jane A Cox; Deborah L McCartney; Tim Doyle; Frances Elmslie; Anand Saggar; Petrus J de Vries; Julian R Sampson
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245
View more
  1 in total

1.  YouTube-videos for patient education in lymphangioleiomyomatosis?

Authors:  Finn M Wilkens; Claudia Ganter; Katharina Kriegsmann; Heinrike Wilkens; Nicolas Kahn; Gillian C Goobie; Christopher J Ryerson; Michael Kreuter
Journal:  Respir Res       Date:  2022-04-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.